- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06266728
T30 for Astigmatism in Digital Device Users (T30FA)
Performance of Total30 for Astigmatism in Digital Device Users
Study Overview
Status
Intervention / Treatment
Detailed Description
Extensive computer use is no longer an employment-specific challenge. Use of digital devices in work, home, and leisure settings is now the norm, and it is now socially expected. While the introduction of high-powered computers and digital devices have greatly improved many aspects of modern life, the pervasive use of digital devices has caused some patients to develop a condition known as Digital Eye Strain (DES). DES has been reported to be as high as 93% the population depending upon how the condition is defined, and its severity has been found to increase with increased digital device time. DES is a condition where patients experience symptoms such as glare, accommodative dysfunction, defocus, fatigue, discomfort, and dryness from digital device use, and these dry eye symptoms may also result in decreased quality of life. While dryness symptoms in DES are likely multifactorial (e.g., contact lens use, systemic disease status), much of the dryness symptoms in DES are probably due to tear film evaporation secondary to having a reduced number of blinks per minute while using digital devices.
Contact lens (CL) discomfort affects most CL wearers with discomfort consistently topping the reasons why established CL wearers drop out of CLs. In fact, studies have consistently found that the frequency of CL dropout is around 20% with this dropout frequency staying relatively stable over the past 20 plus years. This static frequency of CL dropout is surprising since there have been a number of dramatic soft CL innovations during this time frame (e.g., widely available daily disposable CLs, silicone hydrogel CL materials with high oxygen transmissibility, new CL surface coatings). CL discomfort and dropout could be affected by significant time spent on digital devices and DES. Maintaining ocular comfort with satisfactory CL performance (comfort, lack of dryness, and overall good vision) is key to overall success. This could be especially important in patients who wear astigmatic CLs, yet the community currently lacks data on this topic.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Randy Brafford, BS
- Phone Number: 901.252.3660
- Email: rbrafford@sco.edu
Study Contact Backup
- Name: Quentin X Franklin, BS, BA
- Phone Number: 6592064188
- Email: QuentinFranklin@uab.edu
Study Locations
-
-
Kansas
-
Pittsburg, Kansas, United States, 66762
- Kannar Eye Care
-
Contact:
- Shane Kannarr, OD
- Phone Number: 620-235-1737
- Email: skannarr@kannarreyecare.com
-
-
Mississippi
-
Coldwater, Mississippi, United States, 38618
- Coldwater VIsion Center
-
Contact:
- Kristopher May, OD
- Phone Number: 662-224-8000
- Email: kmay@sco.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult (18- to 40-year-old)
- 0.00 LogMAR visual acuity or better in their habitual CLs or by manifest refraction in both eyes
- Smart phone with text messaging capabilities
- Existing wearers of soft, frequent replacement toric CLs within past 6 months
- Frequent digital device user (e.g., phone, iPad, computer, social media, video streaming, etc.) defined as at least 8 hours of usage per day
- Willing to follow the required wear schedule
- Astigmatism ranging from 0.75 D to 2.50 D in each eye
- Willing to wear their CLs at least 13 hours/day
Exclusion Criteria: Have known systemic health conditions that are thought to alter tear film physiology (e.g., Sjögren's syndrome).
- Have a known history of being diagnosed with dry eye disease
- Have a history of ocular surgery within the past 12 months
- Have a history of severe ocular trauma, active ocular infection or inflammation
- Have a history of viral eye disease
- Currently using isotretinoin-derivatives or ocular medications
- Currently using a dry eye treatment including but not limited to artificial tears
- Currently using rewetting drops daily or occasionally
- If they are pregnant or breast feeding
- Need for spectacle add power of any amount (presbyopic)
- Currently wearing T30fA CLs
- Have a history of wearing hard CLs
- Subjects who show excessive lens oscillation with the T30fA lenses during the fitting process yet show 0.0 logMAR acuity, will be excluded from the study.
- Patients who report unstable vision while wearing their habitual or study CLs (e.g., rotational instability of CLs)
- Willing to not use any artificial tears or dry eye treatments during the study
- Willing to not use rewetting drops during the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Total 30 for astigmatism contact lenses
Total30 for Astigmatism Monthly Replacement Contact Lenses
|
Participants must be refit into Total30 for Astigmatism Contact Lenses and wear them over the course of this one month study.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual Analog Scale (VAS) Comfort Scores
Time Frame: Baseline to 1 month of Contact lens wear
|
Participants will receive text message surveys on which they will record the comfort of their lenses throughout various points in the day, during different periods of the 1 month study.
Scores will be recorded on a scale +/- 50 with +50 being the highest level of comfort and -50 being uncomfortable.
|
Baseline to 1 month of Contact lens wear
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00006733
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Refractive Errors
-
Suzan A RattanCompletedRefractive Errors | Refractive SurgeryIraq
-
London School of Hygiene and Tropical MedicineBritish Council for Prevention of Blindness; Tanzanian Society for the BlindCompletedUnder- and Uncorrected Significant Refractive ErrorsTanzania
-
Johnson & Johnson Vision Care, Inc.TerminatedRefractive Error CorrectionUnited States
-
Alcon ResearchCompletedRefractive ErrorsUnited States
-
Alcon ResearchCompletedRefractive ErrorsUnited States
-
Alcon ResearchCompletedRefractive ErrorsUnited States
-
Ohio State UniversityNational Eye Institute (NEI); University of HoustonCompleted
-
Coopervision, Inc.Completed
Clinical Trials on Total30 for Astigmatism Contact Lenses
-
Southern College of OptometryAlcon ResearchRecruitingRefractive Errors | Astigmatism | Contact Lens ComplicationUnited States
-
Alcon ResearchCompleted
-
Johnson & Johnson Vision Care, Inc.CompletedOcular PhysiologyUnited States
-
Ohio State UniversityCompletedContact LensUnited States
-
Alcon ResearchCompletedRefractive ErrorsUnited States
-
Scripps Poway Eyecare and OptometrySengiCompleted
-
University of VirginiaJohnson & Johnson Vision Care, Inc.CompletedAstigmatismUnited States
-
Alcon ResearchCompletedRefractive Errors | Astigmatism | AmetropiaUnited States
-
Bausch & Lomb IncorporatedCompleted
-
University of Alabama at BirminghamAlcon ResearchCompleted